Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/ refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients.

Details

Language :

English

ISSN :

25738348

Volume :

5

Issue :

2

Database :

Complementary Index

Journal :

Cancer Reports

Publication Type :

Academic Journal

Accession number :

155874910

Full Text :

https://doi.org/10.1002/cnr2.1476